GlassScriptPhysician profile
Yadin Bornstein
NPI 1073172813
$1,587.78
in general payments reported to CMS, 2019-2025
8 companies · $1,359 in 2025
The $1,359 reported for 2025 was more than what 77% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $192 · 2024: $36.65 · 2025: $1,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $587.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,061.48 | 2023-2025 | Da Vinci Surgical System |
| Davol INC. | $159.57 | 2023 | Phasix Mesh |
| Abbvie INC. | $125.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.84 | 2025 | Entyvio |
| Solventum Corporation | $46.54 | 2024-2025 | Prevena, V.A.C. Veraflo, Abthera |
| Janssen Biotech, INC. | $39.21 | 2025 | Simponi Aria, Stelara, Simponi |
| Thd America, INC. | $21.86 | 2025 | |
| Ethicon US, LLC | $21.28 | 2024 | Megadyne, Echelon Circular, Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yadin Bornstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.